e-Monitoring of Asthma Therapy to Improve Compliance in children.
- Conditions
- asthma, adherence, inhaled corticosteroids, real time medication monitoring (RTMM), sms-reminder
- Registration Number
- NL-OMON29009
- Lead Sponsor
- Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
1. Children younger than 12 years old;
2. Diagnosed with asthma for at least 6 months;
Exclusion Criteria
Refusal to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of inhalations taken within a 6 hour timeframe around the expected time of inhalation.
- Secondary Outcome Measures
Name Time Method 1. Asthma controll;<br /><br>2. Asthma exacerbations;<br /><br>3. Disease specific quality of life;<br /><br>4. Acceptance of e-monitoring bij parents and children.<br /><br>Moreover, an economic evaluation will be performed adopting a societal perspective, including all relevant healthcare costs and productivity loss of the parents.